Preclinical development of a molecular clamp-stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2.

In the case of MF59‐adjuvanted Sclamp, there was also an apparent reduction in viral load within nasal turbinate tissue, suggesting that protection may extend to the upper respiratory tract; however, this trend did not reach statistical significance.

also in 111,027 other papers